Author details

Full Name

Debyani Chakravarty

Affiliation

Memorial Sloan Kettering Cancer Center

ORCID

Career Start Year

2002

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37849038	Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer.	Cancer Discov	2024
37651310	Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications.	Cancer Discov	2023
38084089	Precision Oncology: 2023 in Review.	Cancer Discov	2023
37898613	Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing.	Nat Commun	2023
37890492	Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers.	Cancer Cell	2023
35165384	Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variants.	Nat Biotechnol	2022
35440569	AKT mutant allele-specific activation dictates pharmacologic sensitivities.	Nat Commun	2022
35796744	Response to Mehta etÂ al.	Genet Med	2022
36458431	Precision Oncology: 2022 in Review.	Cancer Discov	2022
36357680	Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.	Nat Med	2022
36063163	Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).	Genet Med	2022
36228155	Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention.	Clin Cancer Res	2022
36048199	Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort.	Cancer Discov	2022
35101336	Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).	Genet Med	2022
35066956	Computational methods and translational applications for targeted next-generation sequencing platforms.	Genes Chromosomes Cancer	2022
35175857	Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.	J Clin Oncol	2022
34059130	Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients.	Genome Med	2021
33625877	OncoTree: A Cancer Classification System for Precision Oncology.	JCO Clin Cancer Inform	2021
33762738	Clinical cancer genomic profiling.	Nat Rev Genet	2021
35072136	GA4GH: International policies and standards for data sharing across genomic research and healthcare.	Cell Genom	2021
34133209	Therapeutic Implications of Germline Testing in Patients With Advanced Cancers.	J Clin Oncol	2021
34351646	Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes.	Cancer	2021
32193223	The Evolutionary Origins of Recurrent Pancreatic Cancer.	Cancer Discov	2020
32644817	Collaborative, Multidisciplinary Evaluation of Cancer Variants Through Virtual Molecular Tumor Boards Informs Local Clinical Practices.	JCO Clin Cancer Inform	2020
32721511	RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors.	Urology	2020
32246132	A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer.	Nat Genet	2020
31152158	Publisher Correction: The long tail of oncogenic drivers in prostate cancer.	Nat Genet	2019
32914018	Real-World Outcomes of an Automated Physician Support System for Genome-Driven Oncology.	JCO Precis Oncol	2019
32914011	Comprehensive Genomic Analysis of Metastatic Non-Clear-Cell Renal Cell Carcinoma to Identify Therapeutic Targets.	JCO Precis Oncol	2019
31175097	Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations.	Clin Cancer Res	2019
29247016	Accelerating Discovery of Functional Mutant Alleles in Cancer.	Cancer Discov	2018
30137196	A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).	Ann Oncol	2018
30311369	Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes.	Hum Mutat	2018
29610475	The long tail of oncogenic drivers in prostate cancer.	Nat Genet	2018
29683790	Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas.	J Clin Oncol	2018
29625050	Oncogenic Signaling Pathways in The Cancer Genome Atlas.	Cell	2018
27442865	The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.	JAMA Oncol	2017
28336552	Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.	Cancer Discov	2017
28481359	Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.	Nat Med	2017
28472509	Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.	Neuro Oncol	2017
29045506	Clinical and molecular characterization of patients with cancer of unknown primary in the modern era.	Ann Oncol	2017
28777785	Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.	Nat Med	2017
28911072	Oncologist use and perception of large panel next-generation tumor sequencing.	Ann Oncol	2017
28831081	EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines.	Sci Rep	2017
28825054	Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making.	JCO Precis Oncol	2017
28890946	OncoKB: A Precision Oncology Knowledge Base.	JCO Precis Oncol	2017
27807832	Transcriptome and Proteome Analyses of TNFAIP8 Knockdown Cancer Cells Reveal New Insights into Molecular Determinants of Cell Survival and Tumor Progression.	Methods Mol Biol	2017
24120142	The somatic genomic landscape of glioblastoma.	Cell	2013
22323597	Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.	Proc Natl Acad Sci U S A	2012
22105174	Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation.	J Clin Invest	2011

1 - 50 of 53

Sebastian Uhrig

National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)

Career Start Year 2016

Number of shared co-authors 7

Zachary L Skidmore

Washington University in St. Louis School of Medicine

Career Start Year 2015

Number of shared co-authors 25

Katie M Campbell

McDonnell Genome Institute, Washington University School of Medicine

Career Start Year 2014

Number of shared co-authors 22

Daniel H Hovelson

Michigan Center for Translational Pathology, University of Michigan ann arbor

Career Start Year 2014

Number of shared co-authors 18

Erica K Barnell

McDonnell Genome Institute, Washington University School of Medicine

Career Start Year 2014

Number of shared co-authors 25

Sahil Seth

The University of Texas MD Anderson Cancer Center

Career Start Year 2014

Number of shared co-authors 45

Mara Rosenberg

Broad Institute of MIT and Harvard

Career Start Year 2013

Number of shared co-authors 47

Yang Shao

Nanjing Geneseeq Technology Inc.

Career Start Year 2012

Number of shared co-authors 0

Gunes Gundem

Memorial Sloan Kettering Cancer Center

Career Start Year 2010

Number of shared co-authors 19

Oscar Krijgsman

The Netherlands Cancer Institute

Career Start Year 2008

Number of shared co-authors 2

Martina Kirchner

Institute of Pathology, University Hospital Heidelberg

Career Start Year 2007

Number of shared co-authors 7

Francine B de Abreu

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 2007

Number of shared co-authors 1

John Paul Shen

The University of Texas MD Anderson Cancer Center

Career Start Year 2006

Number of shared co-authors 3

Sadakatsu Ikeda

Tokyo Medical and Dental University Hospital

Career Start Year 2006

Number of shared co-authors 2

Jianhua Zhang

University of Texas MD Anderson Cancer Center

Career Start Year 2003

Number of shared co-authors 45

Trevor J Pugh

Princess Margaret Cancer Centre, University Health Network

Career Start Year 2003

Number of shared co-authors 36

Jonathan R Dry

Present Address: Tempus Labs Inc.

Career Start Year 2003

Number of shared co-authors 7

Sherri Z Millis

Foundation Medicine Inc

Career Start Year 2003

Number of shared co-authors 6

Aik Choon Tan

Huntsman Cancer Institute, The University of Utah

Career Start Year 2003

Number of shared co-authors 1

Volker Endris

Institute of Pathology, University Hospital Heidelberg

Career Start Year 2001

Number of shared co-authors 9

Nikhil Wagle

Dana-Farber Cancer Institute

Career Start Year 2000

Number of shared co-authors 35

Richard B Schwab

Department of Medicine and Moores Cancer Center, University of California San Diego

Career Start Year 2000

Number of shared co-authors 1

Martijn P Lolkema

Erasmus MC Cancer Institute

Career Start Year 1999

Number of shared co-authors 15

Kenna R Mills Shaw

The University of Texas MD Anderson Cancer Center

Career Start Year 1999

Number of shared co-authors 49

Anthony J Iafrate

Massachusetts General Hospital

Career Start Year 1997

Number of shared co-authors 26

Stefan Fr??hling

German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)

Career Start Year 1996

Number of shared co-authors 15

Jan Budczies

Institute of Pathology, University Hospital Heidelberg

Career Start Year 1996

Number of shared co-authors 9

Siraj M Ali

Foundation Medicine

Career Start Year 1995

Number of shared co-authors 20

Ultan McDermott

Wellcome Sanger Institute

Career Start Year 1993

Number of shared co-authors 14

Paul T Fanta

University of California San Diego Moores Cancer Center

Career Start Year 1992

Number of shared co-authors 1

row(s) 1 - 30 of 30

Nikolaus Schultz

Memorial Sloan Kettering Cancer Center

Co-authored papers 23

Michael F Berger

Co-authored papers 20

Marc Ladanyi

Memorial Sloan Kettering Cancer Center

Co-authored papers 18

Jianjiong Gao

Memorial Sloan Kettering Cancer Center

Co-authored papers 16

Ritika Kundra

Memorial Sloan Kettering Cancer Center

Co-authored papers 14

Barry S Taylor

Memorial Sloan Kettering Cancer Center

Co-authored papers 10

Hongxin Zhang

Memorial Sloan Kettering Cancer Center

Co-authored papers 9

Wassim Abida

Memorial Sloan Kettering Cancer Center

Co-authored papers 8

Alexander Drilon

Memorial Sloan Kettering Cancer Center

Co-authored papers 7

Howard I Scher

Memorial Sloan Kettering Cancer Center

Co-authored papers 7

JosÃ© Baselga

Co-authored papers 6

Gregory J Riely

Memorial Sloan Kettering Cancer Center

Co-authored papers 5

Alex H Wagner

Iowa State University, Mayo Clinic, Nationwide Children's Hospital, The Ohio State University College of Medicine, University of Iowa, Washington University in Saint Louis

Co-authored papers 5

Dmitriy Sonkin

National Cancer Institute

Co-authored papers 5

Cameron Brennan

Co-authored papers 5

Malachi Griffith

Washington University

Co-authored papers 5

Obi L Griffith

Washington University

Co-authored papers 5